Author(s): Sravani Koralla, Asha Deepti Choppala

Email(s): achoppal@gitam.edu

DOI: 10.52711/0974-360X.2025.00247   

Address: Sravani Koralla, Asha Deepti Choppala*
GITAM School of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India – 530045.
*Corresponding Author

Published In:   Volume - 18,      Issue - 4,     Year - 2025


ABSTRACT:
Pyridopyrimidines are fused heterocyclic compounds that have gained significant attention in medicinal chemistry due to their diverse pharmacological activities. These compounds exhibit structural similarity to purines, making them valuable scaffolds for the development of bioactive molecules, particularly in anticancer drug discovery. New Substituted 2,4-diphenyl-12a,13-dihydro-5H-pyrido[2',3':4,5]pyrimido[2,1-b]quinazoline-5,7(12H)-dione (8a-h) derivatives were synthesized and evaluated for their anti-cancer activity. The corresponding pyrido [2, 3-d] pyrimidine derivatives (8a-h) were also synthesized from starting materials. Docking studies were performed and revealed that the synthesised compounds have similar binding modes against the prospective biological targets. The newly synthesized compounds have shown low to moderate reducing activity in the MTT assay.


Cite this article:
Sravani Koralla, Asha Deepti Choppala. Exploring the potency of new Pyridopyrimidine derivatives: Synthesis and biological evaluation. Research Journal of Pharmacy and Technology. 2025;18(4):1725-0. doi: 10.52711/0974-360X.2025.00247

Cite(Electronic):
Sravani Koralla, Asha Deepti Choppala. Exploring the potency of new Pyridopyrimidine derivatives: Synthesis and biological evaluation. Research Journal of Pharmacy and Technology. 2025;18(4):1725-0. doi: 10.52711/0974-360X.2025.00247   Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-4-38


REFERENCES:
1.    Kumar A, Bhagat KK, Singh AK, et al. Medicinal chemistry perspective of pyrido [2,3-d]pyrimidines as anticancer agents. RSC Adv. 2023; 13(10): 6872-6908.
2.    Elzahabi HSA, Nossier ES, Khalifa NM, Alasfoury RA, El-Manawaty MA. Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based on pyrido[2,3-d]pyrimidine scaffold. J Enzyme Inhib Med Chem. 2018; 33(1): 546-557.
3.    Elsherif MA. Antibacterial evaluation and molecular properties of pyrazolo[3,4-b]pyridines and thieno[2,3-b] pyridines. J. Appl. Pharm. Sci. 2021; 11: 118-124.
4.    Attaby FA Abdel-Fattah M, Shaif LM and Elsayed MM. Reactions, Anti-Alzheimer and Anti COX-2 Activities of the Newly Synthesized 2-Substituted Thienopyridines. Curr Org Chem 2009; 13: 1654-1663.
5.    Binsaleh NK, Wigley CA, Whitehead KA, Van Rensburg M, Reynisson J, Pilkington LI, Barker D, Jones S, DempseyHibbert NC. Thieno[2,3-b]pyridine derivatives are potent anti-platelet drugs, inhibiting platelet activation, aggregation and showing synergy with aspirin. Eur. J. Med. Chem. 2018, 143, 1997-2004.
6.    Abdelaziz ME, El-Miligy MMM, Fahmy SM, Mahran MA, Hazzaa AA. Design, synthesis and docking study of pyridine and thieno[2,3-b] pyridine derivatives anticancer PIM-1 kinase inhibitors. Bioorg. Chem. 2018; 80: 674-692.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available